Algorae Pharmaceuticals Limited
1AI
Classificação em ações
#30945
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Preço da ação
$0.00705285
Valor de mercado
$14.30M
Variação (1 dia)
0.00%
Variação (1 ano)
-30.71%
País
AU
Negociar Algorae Pharmaceuticals Limited (1AI)
Categoria
Healthcare
Capitalização de mercado de Algorae Pharmaceuticals Limited(1AI)
Valor de mercado: $14.30M
Em October 2026, Algorae Pharmaceuticals Limited tem uma capitalização de mercado de $14.30M. Isso faz com que Algorae Pharmaceuticals Limited seja a 30945th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Algorae Pharmaceuticals Limited de 2004 a 2026
1AI comparado com o topo de 5 mais populares stocks
